Abstract
Aging impairs skeletal muscle protein synthesis, leading to muscle weakness and atrophy. However, the underlying molecular mechanisms remain poorly understood. Here, we review evidence that mammalian/mechanistic target of rapamycin complex 1 (mTORC1)-mediated and activating transcription factor 4 (ATF4)-mediated amino acid (AA) sensing pathways, triggered by impaired AA delivery to aged skeletal muscle, may play important roles in skeletal muscle aging. Interventions that alleviate age-related impairments in muscle protein synthesis, strength, and/or muscle mass appear to do so by reversing age-related changes in skeletal muscle AA delivery, mTORC1 activity, and/or ATF4 activity. An improved understanding of the mechanisms and roles of AA sensing pathways in skeletal muscle may lead to evidence-based strategies to attenuate sarcopenia.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 796-806 |
| Number of pages | 11 |
| Journal | Trends in Endocrinology and Metabolism |
| Volume | 27 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2016 |
Keywords
- activating transcription factor 4
- general control nonderepressible 2
- leucine
- mammalian/mechanistic target of rapamycin complex 1
- tomatidine
- ursolic acid
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology